Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.575
+0.045 (2.94%)
Mar 9, 2026, 2:15 PM EDT - Market open
Geron Employees
Geron had 229 employees as of December 31, 2024. The number of employees increased by 88 or 62.41% compared to the previous year.
Employees
229
Change (1Y)
88
Growth (1Y)
62.41%
Revenue / Employee
$802,974
Profits / Employee
-$364,629
Market Cap
1.01B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 700 |
| AbCellera Biologics | 596 |
| Xeris Biopharma Holdings | 394 |
| UroGen Pharma | 287 |
| Inhibrx Biosciences | 161 |
| Cullinan Therapeutics | 111 |
| ArriVent BioPharma | 52 |
| GH Research | 50 |
GERN News
- 10 days ago - Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings - Seeking Alpha
- 12 days ago - Geron Corporation (GERN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 14 days ago - Geron Plans to Present at Upcoming Investor Conferences - GlobeNewsWire
- 18 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
- 26 days ago - Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 5 weeks ago - Geron: Underpromise And Overdeliver Could Be The 2026 Strategy (Rating Upgrade) - Seeking Alpha